Kaletra Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year
Conditions:   Hematopoietic and Lymphoid Cell Neoplasm;   Malignant Solid Neoplasm;   Symptomatic COVID-19 Infection Laboratory-Confirmed Interventions:   Drug: Lopinavir/Ritonavir;   Drug: Placebo Administration;   Other: Questionnaire Administration Sponsors:   OHSU Knight Cancer Institute;   Oregon Health and Science University;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 2, 2020 Category: Research Source Type: clinical trials

Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar
Conditions:   Coronavirus;   COVID;   Pneumonia Interventions:   Drug: Darunavir/Cobicistat;   Drug: Lopinavir/Ritonavir Sponsor:   Hamad Medical Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2020 Category: Research Source Type: clinical trials